Xponance’s NuVasive, Inc. NUVA Stock Holding History

Xponance’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8,109	Closed	-$355K	–	1249
2022 Q3	$355K	Buy	8,109 +45	+0.6%	+$2.18K	0.01%	956
2022 Q2	$396K	Buy	8,064 +485	+6%	+$26K	0.01%	942
2022 Q1	$430K	Sell	7,579 -168	-2%	-$8.92K	0.01%	946
2021 Q4	$407K	Buy	7,747 +18	+0.2%	+$978	0.01%	974
2021 Q3	$463K	Sell	7,729 -421	-5%	-$26K	0.01%	922
2021 Q2	$552K	Buy	8,150 +2,518	+45%	+$172K	0.01%	881
2021 Q1	$369K	Sell	5,632 -1,194	-17%	-$71.6K	0.01%	901
2020 Q4	$385K	Sell	6,826 -21	-0.3%	-$1.03K	0.01%	864
2020 Q3	$333K	Sell	6,847 -136	-2%	-$7.33K	0.01%	816
2020 Q2	$389K	Buy	+6,983	New	+$404K	0.01%	724

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Xponance's NUVA Position: Q4 2022 in Review

Xponance sold out of NuVasive, Inc. (NUVA) in Q4 2022, closing a stake of 8,109 shares — an estimated $355K sold.

Xponance first reported a position in NUVA in Q2 2020 and held it in 10 quarters. The position peaked at $552K in Q2 2021. 235 funds tracked by Wall St. Rank hold NUVA as of Q4 2022.

Xponance reported no remaining NuVasive, Inc. position as of Q4 2022 after selling out during the quarter.
Xponance sold 8,109 NuVasive, Inc. shares in Q4 2022, an estimated $355K.
Xponance first reported a position in NuVasive, Inc. in Q2 2020 and held it in 10 quarters.
Xponance's NuVasive, Inc. position peaked at $552K in Q2 2021.
235 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2022.

Based on Xponance's 13F filing for Q4 2022, filed 24 Jan 2023.